Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386041718> ?p ?o ?g. }
- W4386041718 endingPage "S119" @default.
- W4386041718 startingPage "S118" @default.
- W4386041718 abstract "BACKGROUND CONTEXT Prior studies have associated increased BMI with greater EBL. Yet, EBL in the context of complex adult spinal deformity (ASD) surgery may inherently be elevated, and the interaction between BMI, invasiveness, and EBL has yet to be studied. Additionally, there is a lack of literature assessing relative TXA dosing within these subsets of patients to minimize the risk for transfusion. PURPOSE To define a threshold of EBL based on patient-specific factors that is associated with increased risk of transfusion for complex adult spinal deformity patients, and identify TXA dosing associated with remaining below resulting thresholds. STUDY DESIGN/SETTING Retrospective multi-center. PATIENT SAMPLE A total of 439 complex ASD patients. OUTCOME MEASURES Complication, medication dosage, peri-op. METHODS Complex ASD patients with baseline (BL) and up perioperative (6W) data were isolated. Patients were grouped by BMI (Underweight [<18.5 kg/m2]), Healthy Weight [18.5-25 kg/m2], Overweight [25-30 kg/m2], and Obese [>30 kg/m2]), ISSG-Invasiveness (tertiles of low, moderate, high) and deformity correction per δ6W-BL C7S1 SVA, S1PT, max. kyphosis, and PI-LL (tertiles of low, moderate, high). ANOVA determined differences in EBL by BMI, invasiveness, and deformity correction. Logistic regressions and CIT analysis provided thresholds of EBL requiring intraoperative blood transfusion, along with TXA loading and maintenance dose associated with achievement of subsequent thresholds within invasiveness tertiles and controlling for relevant covariates. RESULTS A total of 302 complex ASD patients (average of 60.4±15.4 years, 69% female, BMI of 27.4±5.8 kg/m2) were isolated who underwent surgical correction with on average 12.5±3.8 levels fused, operative time 467.4±158.1 mins, length of stay 7.0±6.1 days, and EBL 1638.1±1321.3 mL. By BMI, 3.0% were underweight, 32.1% healthy weight, 36.4% overweight, and 28.5% obese. Patients with greater EBL had greater mean rates of post-op ICU admission or prolonged stay (p=.018) but not medical (p=.713), cardiac (p=.364), or neurologic (p=.110) complications. When controlled for levels fused and OR time, greater EBL was predictive of ICU admission or prolonged stay (OR: 1.000 (1.0-1.0), p=.034). CIT determined EBL thresholds associated with transfusion of 800 mL for Low (p=.029), 2100 mL for Moderate (p<.001), and 2600 mL (p12.3 mg/kg loading (p=.029)/≥3.0 mg/kg/hr (p=.019) maintenance for Low invasiveness, >23.5 mg loading (p=.037)/≥3.25 mg/kg/hr maintenance (p=.024) for Moderate invasiveness, and >25.9 mg/kg loading (p=.004)/≥4.7 mg/kg/hr maintenance (p=.002) for High invasiveness groups. CONCLUSIONS Prior research has demonstrated correlations between body mass index (BMI), surgical invasiveness, and estimated operative blood loss (EBL), but this had yet to be studied within complex adult spinal deformity surgery. The present study demonstrates that EBL thresholds predictive of transfusion risk differ based on the degree of surgical invasiveness and deformity correction required. Predictive analysis also reveals that with increasing invasiveness tertiles, incrementally increased dosage of tranexamic acid is associated with maintaining blood loss below said thresholds. FDA Device/Drug Status This abstract does not discuss or include any applicable devices or drugs. Prior studies have associated increased BMI with greater EBL. Yet, EBL in the context of complex adult spinal deformity (ASD) surgery may inherently be elevated, and the interaction between BMI, invasiveness, and EBL has yet to be studied. Additionally, there is a lack of literature assessing relative TXA dosing within these subsets of patients to minimize the risk for transfusion. To define a threshold of EBL based on patient-specific factors that is associated with increased risk of transfusion for complex adult spinal deformity patients, and identify TXA dosing associated with remaining below resulting thresholds. Retrospective multi-center. A total of 439 complex ASD patients. Complication, medication dosage, peri-op. Complex ASD patients with baseline (BL) and up perioperative (6W) data were isolated. Patients were grouped by BMI (Underweight [<18.5 kg/m2]), Healthy Weight [18.5-25 kg/m2], Overweight [25-30 kg/m2], and Obese [>30 kg/m2]), ISSG-Invasiveness (tertiles of low, moderate, high) and deformity correction per δ6W-BL C7S1 SVA, S1PT, max. kyphosis, and PI-LL (tertiles of low, moderate, high). ANOVA determined differences in EBL by BMI, invasiveness, and deformity correction. Logistic regressions and CIT analysis provided thresholds of EBL requiring intraoperative blood transfusion, along with TXA loading and maintenance dose associated with achievement of subsequent thresholds within invasiveness tertiles and controlling for relevant covariates. A total of 302 complex ASD patients (average of 60.4±15.4 years, 69% female, BMI of 27.4±5.8 kg/m2) were isolated who underwent surgical correction with on average 12.5±3.8 levels fused, operative time 467.4±158.1 mins, length of stay 7.0±6.1 days, and EBL 1638.1±1321.3 mL. By BMI, 3.0% were underweight, 32.1% healthy weight, 36.4% overweight, and 28.5% obese. Patients with greater EBL had greater mean rates of post-op ICU admission or prolonged stay (p=.018) but not medical (p=.713), cardiac (p=.364), or neurologic (p=.110) complications. When controlled for levels fused and OR time, greater EBL was predictive of ICU admission or prolonged stay (OR: 1.000 (1.0-1.0), p=.034). CIT determined EBL thresholds associated with transfusion of 800 mL for Low (p=.029), 2100 mL for Moderate (p<.001), and 2600 mL (p12.3 mg/kg loading (p=.029)/≥3.0 mg/kg/hr (p=.019) maintenance for Low invasiveness, >23.5 mg loading (p=.037)/≥3.25 mg/kg/hr maintenance (p=.024) for Moderate invasiveness, and >25.9 mg/kg loading (p=.004)/≥4.7 mg/kg/hr maintenance (p=.002) for High invasiveness groups. Prior research has demonstrated correlations between body mass index (BMI), surgical invasiveness, and estimated operative blood loss (EBL), but this had yet to be studied within complex adult spinal deformity surgery. The present study demonstrates that EBL thresholds predictive of transfusion risk differ based on the degree of surgical invasiveness and deformity correction required. Predictive analysis also reveals that with increasing invasiveness tertiles, incrementally increased dosage of tranexamic acid is associated with maintaining blood loss below said thresholds." @default.
- W4386041718 created "2023-08-22" @default.
- W4386041718 creator A5000781076 @default.
- W4386041718 creator A5002990814 @default.
- W4386041718 creator A5005288592 @default.
- W4386041718 creator A5010502968 @default.
- W4386041718 creator A5015788559 @default.
- W4386041718 creator A5016221728 @default.
- W4386041718 creator A5016755684 @default.
- W4386041718 creator A5023093297 @default.
- W4386041718 creator A5023107984 @default.
- W4386041718 creator A5031911793 @default.
- W4386041718 creator A5033588320 @default.
- W4386041718 creator A5035148784 @default.
- W4386041718 creator A5036688363 @default.
- W4386041718 creator A5037055228 @default.
- W4386041718 creator A5041564586 @default.
- W4386041718 creator A5043686090 @default.
- W4386041718 creator A5045070551 @default.
- W4386041718 creator A5045395453 @default.
- W4386041718 creator A5046932102 @default.
- W4386041718 creator A5048131399 @default.
- W4386041718 creator A5049337845 @default.
- W4386041718 creator A5056677929 @default.
- W4386041718 creator A5059037480 @default.
- W4386041718 creator A5061204327 @default.
- W4386041718 creator A5061450966 @default.
- W4386041718 creator A5062079201 @default.
- W4386041718 creator A5062340233 @default.
- W4386041718 creator A5062776596 @default.
- W4386041718 creator A5063218432 @default.
- W4386041718 creator A5070541802 @default.
- W4386041718 creator A5071664246 @default.
- W4386041718 creator A5076054030 @default.
- W4386041718 creator A5080429360 @default.
- W4386041718 creator A5084499569 @default.
- W4386041718 creator A5084965073 @default.
- W4386041718 creator A5089291690 @default.
- W4386041718 creator A5089944759 @default.
- W4386041718 date "2023-09-01" @default.
- W4386041718 modified "2023-10-14" @default.
- W4386041718 title "P22. Identifying tranexamic acid dosing predictive of decreased risk of intraoperative transfusion accounting for body mass index and surgical invasiveness in complex adult spinal deformity surgery" @default.
- W4386041718 doi "https://doi.org/10.1016/j.spinee.2023.06.247" @default.
- W4386041718 hasPublicationYear "2023" @default.
- W4386041718 type Work @default.
- W4386041718 citedByCount "0" @default.
- W4386041718 crossrefType "journal-article" @default.
- W4386041718 hasAuthorship W4386041718A5000781076 @default.
- W4386041718 hasAuthorship W4386041718A5002990814 @default.
- W4386041718 hasAuthorship W4386041718A5005288592 @default.
- W4386041718 hasAuthorship W4386041718A5010502968 @default.
- W4386041718 hasAuthorship W4386041718A5015788559 @default.
- W4386041718 hasAuthorship W4386041718A5016221728 @default.
- W4386041718 hasAuthorship W4386041718A5016755684 @default.
- W4386041718 hasAuthorship W4386041718A5023093297 @default.
- W4386041718 hasAuthorship W4386041718A5023107984 @default.
- W4386041718 hasAuthorship W4386041718A5031911793 @default.
- W4386041718 hasAuthorship W4386041718A5033588320 @default.
- W4386041718 hasAuthorship W4386041718A5035148784 @default.
- W4386041718 hasAuthorship W4386041718A5036688363 @default.
- W4386041718 hasAuthorship W4386041718A5037055228 @default.
- W4386041718 hasAuthorship W4386041718A5041564586 @default.
- W4386041718 hasAuthorship W4386041718A5043686090 @default.
- W4386041718 hasAuthorship W4386041718A5045070551 @default.
- W4386041718 hasAuthorship W4386041718A5045395453 @default.
- W4386041718 hasAuthorship W4386041718A5046932102 @default.
- W4386041718 hasAuthorship W4386041718A5048131399 @default.
- W4386041718 hasAuthorship W4386041718A5049337845 @default.
- W4386041718 hasAuthorship W4386041718A5056677929 @default.
- W4386041718 hasAuthorship W4386041718A5059037480 @default.
- W4386041718 hasAuthorship W4386041718A5061204327 @default.
- W4386041718 hasAuthorship W4386041718A5061450966 @default.
- W4386041718 hasAuthorship W4386041718A5062079201 @default.
- W4386041718 hasAuthorship W4386041718A5062340233 @default.
- W4386041718 hasAuthorship W4386041718A5062776596 @default.
- W4386041718 hasAuthorship W4386041718A5063218432 @default.
- W4386041718 hasAuthorship W4386041718A5070541802 @default.
- W4386041718 hasAuthorship W4386041718A5071664246 @default.
- W4386041718 hasAuthorship W4386041718A5076054030 @default.
- W4386041718 hasAuthorship W4386041718A5080429360 @default.
- W4386041718 hasAuthorship W4386041718A5084499569 @default.
- W4386041718 hasAuthorship W4386041718A5084965073 @default.
- W4386041718 hasAuthorship W4386041718A5089291690 @default.
- W4386041718 hasAuthorship W4386041718A5089944759 @default.
- W4386041718 hasConcept C126322002 @default.
- W4386041718 hasConcept C141071460 @default.
- W4386041718 hasConcept C151730666 @default.
- W4386041718 hasConcept C2777288759 @default.
- W4386041718 hasConcept C2779343474 @default.
- W4386041718 hasConcept C2779637338 @default.
- W4386041718 hasConcept C2780014101 @default.
- W4386041718 hasConcept C2780221984 @default.
- W4386041718 hasConcept C2780586474 @default.
- W4386041718 hasConcept C2780955175 @default.
- W4386041718 hasConcept C2781121325 @default.
- W4386041718 hasConcept C2991743468 @default.
- W4386041718 hasConcept C2992931878 @default.
- W4386041718 hasConcept C31174226 @default.